Professor William Hwang
Professor William Hwang is currently Medical Director of the National Cancer Centre of Singapore (NCCS), Chair of the Oncology Academic Clinical Programme (ACP) in the SingHealth Duke-NUS Academic Medical Centre, Head of the SingHealth Duke-NUS Cell Therapy Centre, and one of the research faculty in the Duke-NUS Cancer and Stem Cell Biology (CSCB) programme. He is serving as Chairman, Biobanking Advisory, Ministry of Health (MOH); Co-Chair, National Advisory Committee on Cancer Care (NACC), MOH; Co-Chair, Cell, Tissue and Gene Therapy (CTGT) Regulations workgroup, MOH; Member, Hematopoietic Stem Cell Transplant Regulations workgroup, MOH. He is also Board Organising Committee (BOC) member of the Singapore Translational Cancer Consortium.
He has previously served as Medical Director of the Singapore Cord Blood Bank, Head for the Department of Haematology in the Singapore General Hospital and Head of the SingHealth Duke-NUS Blood Cancer Centre as well as Director for SingHealth Transplant.
He was previously President of the World Marrow Donor Association (WMDA), and Advisory Board member of the Centre for International Blood and Marrow Transplant Research (CIBMTR, based in the USA). He served as Congress President for the 2016 Asia Pacific Blood and Marrow Transplant Group (APBMT) meeting and currently serves as Executive Board member of the APBMT.
Prof Hwang has published over 120 papers in medicine and science, particularly in the field of haematology and HSCT.